These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 9266941)

  • 21. Treatment of chronic lymphocytic leukaemia in three dogs with melphalan and prednisolone.
    Fujino Y; Sawamura S; Kurakawa N; Hisasue M; Masuda K; Ohno K; Tsujimoto H
    J Small Anim Pract; 2004 Jun; 45(6):298-303. PubMed ID: 15206475
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The two CD23 isoforms display differential regulation in chronic lymphocytic leukaemia.
    Fournier S; Yang LP; Delespesse G; Rubio M; Biron G; Sarfati M
    Br J Haematol; 1995 Feb; 89(2):373-9. PubMed ID: 7873388
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Induction of latent membrane protein expression in in vitro Epstein-Barr virus-infected leukaemic B lymphocytes by interleukin 4 and antibodies to CD40.
    Crawford DH; Thomas JA; Gregory CD; Catovsky D; Chaggar K
    Leukemia; 1995 May; 9(5):747-53. PubMed ID: 7539512
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Potentiation of chlorambucil cytotoxicity in B-cell chronic lymphocytic leukemia by inhibition of DNA-dependent protein kinase activity using wortmannin.
    Christodoulopoulos G; Muller C; Salles B; Kazmi R; Panasci L
    Cancer Res; 1998 May; 58(9):1789-92. PubMed ID: 9581813
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of decreased production of interleukin-10 and interferon-gamma in spontaneous apoptosis of B-chronic lymphocytic leukemia lymphocytes in vitro.
    Djurdjevic P; Zelen I; Ristic P; Baskic D; Popovic S; Arsenijevic N
    Arch Med Res; 2009 Jul; 40(5):357-63. PubMed ID: 19766898
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Heterogenous response of B lymphocytes to transforming growth factor-beta in B-cell chronic lymphocytic leukaemia: correlation with the expression of TGF-beta receptors.
    Lagneaux L; Delforge A; Bron D; Massy M; Bernier M; Stryckmans P
    Br J Haematol; 1997 Jun; 97(3):612-20. PubMed ID: 9207409
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interleukin-4 (IL-4) inhibits proliferation and spontaneous cytokine release by chronic lymphocytic leukaemia cells.
    Reittie JE; Hoffbrand AV
    Leuk Res; 1994 Jan; 18(1):55-60. PubMed ID: 8289467
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro effects of B cell growth and maturation factor on B-CLL lymphocytes.
    Karray S; Emilie D; Galanaud P
    Nouv Rev Fr Hematol (1978); 1988; 30(5-6):275-8. PubMed ID: 3065728
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interleukin 4 protects chronic lymphocytic leukemic B cells from death by apoptosis and upregulates Bcl-2 expression.
    Dancescu M; Rubio-Trujillo M; Biron G; Bron D; Delespesse G; Sarfati M
    J Exp Med; 1992 Nov; 176(5):1319-26. PubMed ID: 1402678
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alpha-interferon (alpha-IFN) protects B-chronic lymphocytic leukaemia cells from apoptotic cell death in vitro.
    Panayiotidis P; Ganeshaguru K; Jabbar SA; Hoffbrand AV
    Br J Haematol; 1994 Jan; 86(1):169-73. PubMed ID: 8011526
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Actions of the selective protein kinase C inhibitor PKC412 on B-chronic lymphocytic leukemia cells in vitro.
    Ganeshaguru K; Wickremasinghe RG; Jones DT; Gordon M; Hart SM; Virchis AE; Prentice HG; Hoffbrand AV; Man A; Champain K; Csermak K; Mehta AB
    Haematologica; 2002 Feb; 87(2):167-76. PubMed ID: 11836167
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modulation of the human equilibrative nucleoside transporter1 (hENT1) activity by IL-4 and PMA in B cells from chronic lymphocytic leukemia.
    Fernández Calotti P; Galmarini CM; Cañones C; Gamberale R; Saénz D; Avalos JS; Chianelli M; Rosenstein R; Giordano M
    Biochem Pharmacol; 2008 Feb; 75(4):857-65. PubMed ID: 18078872
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The novel sequence-specific DNA cross-linking agent SJG-136 (NSC 694501) has potent and selective in vitro cytotoxicity in human B-cell chronic lymphocytic leukemia cells with evidence of a p53-independent mechanism of cell kill.
    Pepper CJ; Hambly RM; Fegan CD; Delavault P; Thurston DE
    Cancer Res; 2004 Sep; 64(18):6750-5. PubMed ID: 15374993
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Different proliferative and survival capacity of CLL-cells in a newly established in vitro model for pseudofollicles.
    Plander M; Seegers S; Ugocsai P; Diermeier-Daucher S; Iványi J; Schmitz G; Hofstädter F; Schwarz S; Orsó E; Knüchel R; Brockhoff G
    Leukemia; 2009 Nov; 23(11):2118-28. PubMed ID: 19657365
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Valproic acid induces apoptosis in chronic lymphocytic leukemia cells through activation of the death receptor pathway and potentiates TRAIL response.
    Lagneaux L; Gillet N; Stamatopoulos B; Delforge A; Dejeneffe M; Massy M; Meuleman N; Kentos A; Martiat P; Willems L; Bron D
    Exp Hematol; 2007 Oct; 35(10):1527-37. PubMed ID: 17697742
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression and function of the FAS antigen in B chronic lymphocytic leukemia and hairy cell leukemia.
    Panayiotidis P; Ganeshaguru K; Foroni L; Hoffbrand AV
    Leukemia; 1995 Jul; 9(7):1227-32. PubMed ID: 7543175
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relation of P-glycoprotein expression with spontaneous in vitro apoptosis in B-cell chronic lymphocytic leukemia.
    Jamroziak K; Smolewski P; Cebula B; Szmigielska-Kaplon A; Darzynkiewicz Z; Robak T
    Neoplasma; 2004; 51(3):181-7. PubMed ID: 15254670
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of the in vitro effects of the anti-CD20 antibodies rituximab and GA101 on chronic lymphocytic leukaemia cells.
    Patz M; Isaeva P; Forcob N; Müller B; Frenzel LP; Wendtner CM; Klein C; Umana P; Hallek M; Krause G
    Br J Haematol; 2011 Feb; 152(3):295-306. PubMed ID: 21155758
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chlorambucil resistance in B-cell chronic lymphocytic leukaemia is mediated through failed Bax induction and selection of high Bcl-2-expressing subclones.
    Pepper C; Thomas A; Hoy T; Bentley P
    Br J Haematol; 1999 Mar; 104(3):581-8. PubMed ID: 10086798
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low-molecular weight B cell growth factor (BCGF-12KD) as an autocrine growth factor in B cell chronic lymphocytic leukemia.
    Fournier S; Jackson J; Kumar A; King T; Sharma S; Biron G; Rubio M; Delespesse G; Sarfati M
    Eur J Immunol; 1992 Jul; 22(7):1927-30. PubMed ID: 1623931
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.